Elevated serum HE4 levels as a novel biomarker of disease severity and hepatic fibrosis in autoimmune hepatitis
CONCLUSIONS: Serum HE4 levels were found to be elevated in AIH-LC patients and exhibited a strong correlation with the severity of hepatic fibrosis, thus supporting their potential clinical value as a novel biomarker of disease severity and hepatic fibrosis in AIH.PMID:38643819 | DOI:10.1016/j.cca.2024.119682
Source: International Journal of Clinical Chemistry - Category: Chemistry Authors: Zhi Yu Caina Nian Wenmei Sun Xinhua Liu Xueyuan Nian Source Type: research
More News: Autoimmune Disease | Chemistry | Children | Cirrhosis | Hepatitis | Liver | Study | Urology & Nephrology